Selected Peer Reviewed Research
epidermolysis bullosa
Chiou, A., Choi, S., Barriga, M., Dutt-Singkh, Y., Solis, D., & Nazaroff, J. et al. (2020). Phase 2 trial of a neurokinin-1 receptor antagonist for the treatment of chronic itch in patients with epidermolysis bullosa: A randomized clinical trial. Journal Of The American Academy Of Dermatology, 82(6), 1415-1421. doi: 10.1016/j.jaad.2019.09.014
Technology & Public Health
Chan, W., Srivastava, R., Damaraju, N., Do, H., Burnett, G., & MacFarlane, J. et al. (2021). Automated detection of skin reactions in epicutaneous patch testing using machine learning. British Journal Of Dermatology, 185(2), 456-458. doi: 10.1111/bjd.20141
Lee, K., Lee, I., Okhovat, J., Ko, J., Powers, J., & Ellis, D. et al. (2020). Innovation interest within dermatology: a needs assessment for novel thought processes. Archives Of Dermatological Research. doi: 10.1007/s00403-020-02118-6
Nelson, C., Pérez-Chada, L., Creadore, A., Li, S., Lo, K., & Manjaly, P. et al. (2020). Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening. JAMA Dermatology, 156(5), 501. doi:10.1001/jamadermatol.2019.5014
Kovarik, C., Lee, I., Ko, J., Adamson, A., Otley, C., & Kvedar, J. et al. (2019). Commentary: Position statement on augmented intelligence (AuI). Journal Of The American Academy Of Dermatology, 81(4), 998-1000. doi: 10.1016/j.jaad.2019.06.032
Novoa, R., Gevaert, O., & Ko, J. (2019). Marking the Path Toward Artificial Intelligence–Based Image Classification in Dermatology. JAMA Dermatology, 155(10), 1105. doi: 10.1001/jamadermatol.2019.1633
Schlessinger D., Chhor G., Gevaert O., Swetter S., Ko J., Novoa R. (2019). Artificial intelligence and dermatology: opportunities, challenges, and future directions. Semin Cutan Med Surg. 2019 Mar 1;38(1):E31-37. doi: 10.12788/j.sder.2019.. PMID: 31051021.
Narla, A., Kuprel, B., Sarin, K., Novoa, R., & Ko, J. (2018). Automated Classification of Skin Lesions: From Pixels to Practice. Journal Of Investigative Dermatology, 138(10), 2108-2110. doi: 10.1016/j.jid.2018.06.175
Esteva, A., Kuprel, B., Novoa, R., Ko, J., Swetter, S., Blau, H., & Thrun, S. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115-118. doi: 10.1038/nature21056
Skin Cancer
Hirotsu KE, Rana J, Wang JY, Raghavan SS, Rieger KE, Srinivas S, Fan AC, Kwong BY, Novoa RA, Zaba LC. J Am Acad Dermatol. 2020 Dec 7:S0190-9622(20)33156-X. doi: 10.1016/j.jaad.2020.11.067. Online ahead of print.
Nakamoto, R., C Zaba, L., Rosenberg, J., Arani Reddy, S., W Nobashi, T., & Ferri, V. et al. (2020). Imaging Characteristics and Diagnostic Performance of 2-deoxy-2-[18F]fluoro-d-Glucose PET/CT for Melanoma Patients Who Demonstrate Hyperprogressive Disease When Treated with Immunotherapy. Molecular Imaging And Biology. doi: 10.1007/s11307-020-01526-4
Maloney, N., Nguyen, K., Bach, D., & Zaba, L. (2020). Sites of distant metastasis in Merkel cell carcinoma differ by primary tumor site and are of prognostic significance: a population-based study in the Surveillance, Epidemiology, and End Results database from 2010-2016. Journal Of The American Academy Of Dermatology. doi: 10.1016/j.jaad.2020.08.023
Tabata, M., Novoa, R., Bui, N., & Zaba, L. (2020). Successful treatment of HIV-negative Kaposi sarcoma with ipilimumab and nivolumab and concurrent management of baseline psoriasis and bullous pemphigoid. JAAD Case Reports, 6(5), 447-449. doi: 10.1016/j.jdcr.2020.03.001
Nakamoto, R., Zaba, L., Rosenberg, J., Reddy, S., Nobashi, T., & Davidzon, G. et al. (2020). Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy. European Journal Of Nuclear Medicine And Molecular Imaging. doi: 10.1007/s00259-020-04792-0
Ransohoff, K., Wu, W., Cho, H., Chahal, H., Lin, Y., & Dai, H. et al. (2017). Two-stage genome-wide association study identifies a novel susceptibility locus associated with melanoma. Oncotarget, 8(11), 17586-17592. doi: 10.18632/oncotarget.15230
Cai, E., Sun, B., Chiang, A., Rogers, A., Bernet, L., & Cheng, B. et al. (2017). Postzygotic Mutations in Beta-Actin Are Associated with Becker’s Nevus and Becker’s Nevus Syndrome. Journal Of Investigative Dermatology, 137(8), 1795-1798. doi: 10.1016/j.jid.2017.03.017
Kuo, K., Batra, P., Cho, H., Li, S., Chahal, H., & Rieger, K. et al. (2017). Correlates of multiple basal cell carcinoma in a retrospective cohort study: Sex, histologic subtypes, and anatomic distribution. Journal Of The American Academy Of Dermatology, 77(2), 233-234.e2. doi: 10.1016/j.jaad.2017.02.047
Chahal, H., Wu, W., Ransohoff, K., Yang, L., Hedlin, H., & Desai, M. et al. (2016). Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma. Nature Communications, 7(1). doi: 10.1038/ncomms12510
Jaju P., Nguyen C., Mah A., Atwood S., Li J., Zia A., Chang A., Oro A., Tang J., Lee C., Sarin K. (2015). Mutations in the Kinetochore Gene KNSTRN in Basal Cell Carcinoma. J Invest Dermatol. 2015 Dec;135(12):3197-3200. doi: 10.1038/jid.2015.339. Epub 2015 Sep 8. Erratum in: J Invest Dermatol. 2016 Apr;136(4):882. Nguyen, Christine B [corrected to Nguyen, Christie B]. PMID: 26348826; PMCID: PMC4747638.
Ransohoff, K., Tang, J., & Sarin, K. (2015). Squamous Change in Basal-Cell Carcinoma with Drug Resistance. New England Journal Of Medicine, 373(11), 1079-1082. doi: 10.1056/nejmc1504261
Inflammatory Disease
Liu Q, Zaba LC, Satpathy AT, Longmire M, Zhang W, Li K, Granja J, Guo C, Lin J, Li R, Tolentino K, Kania G, Distler O, Fiorentino D, Chung L, Qu K, Chang HY. Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis. Nat Commun. 2020 Nov 17;11(1):5843. doi: 10.1038/s41467-020-19702-z. Erratum in: Nat Commun. 2020 Dec 14;11(1):6416. PMID: 33203843; PMCID: PMC7672105.
Zhu, G., Kang, K., Chen, J., Novoa, R., Brown, R., & Chiou, A. et al. (2020). Inflammatory alopecia in patients on dupilumab: a retrospective cohort study at an academic institution. Journal Of The European Academy Of Dermatology And Venereology, 34(4). doi: 10.1111/jdv.16094
Chen, J., Honari, G., & Silverberg, J. (2020). Eczema, targeted therapeutics, and allergy diagnostics: the need for greater clarity on what we are treating. Journal Of The European Academy Of Dermatology And Venereology, 34(9). doi: 10.1111/jdv.16445
Kim, T., Taylor, J., Maibach, H., Chen, J., & Honari, G. (2020). Photopatch Testing Among Members of the American Contact Dermatitis Society. Dermatitis, 31(1), 59-67. doi: 10.1097/der.0000000000000535
Choi, S., Zhu, G., Lewis, M., Honari, G., Chiou, A., Ko, J., & Chen, J. (2020). Dupilumab treatment of nummular dermatitis: A retrospective cohort study. Journal Of The American Academy Of Dermatology, 82(5), 1252-1255. doi: 10.1016/j.jaad.2019.12.054
Zhu, G., Honari, G., Ko, J., Chiou, A., & Chen, J. (2020). Dupilumab for occupational irritant hand dermatitis in a nonatopic individual: A case report. JAAD Case Reports, 6(4), 296-298. doi: 10.1016/j.jdcr.2020.02.010
Zhu, G., Chen, J., Chiou, A., Ko, J., & Honari, G. (2019). Assessment of the Development of New Regional Dermatoses in Patients Treated for Atopic Dermatitis With Dupilumab. JAMA Dermatology, 155(7), 850. doi: 10.1001/jamadermatol.2019.0109
Cho, H., Fiorentino, D., Lewis, M., Sirota, M., & Sarin, K. (2016). Identification of Alpha-Adrenergic Agonists as Potential Therapeutic Agents for Dermatomyositis through Drug-Repurposing Using Public Expression Datasets. Journal Of Investigative Dermatology, 136(7), 1517-1520. doi: 10.1016/j.jid.2016.03.001